Sapropterin dihydrochloride 100 MG Oral Tablet — RxCUI 1486687
RxNorm drug concept · Semantic clinical drug
RxCUI 1486687
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1486687
Official nameSapropterin dihydrochloride 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assapropterin dihydrochloride 100 MG Soluble Tablet
FDA products mapped9
Package NDCs mapped13
Reported Medicaid activity (SDUD)1,689 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sapropterin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sapropterin gives your body more of a helper molecule called BH4 that the enzyme responsible for breaking down phenylalanine needs to work. If you have BH4-responsive PKU, this can...
- What exactly does sapropterin do, and why do I still have to follow a special diet?
- Your doctor will check your blood phenylalanine levels regularly after you start the medication. If the drug is working, your levels should start to drop within the first 24 hours,...
- How will I know if sapropterin is actually working for me?
🕸️ Concept Web — How Sapropterin dihydrochloride 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sapropterin dihydrochloride 100 MG Oral Tablet
RxCUI 1486687 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Sapropterin
753340IN -
Sapropterin dihydrochloride
753341PIN
-
Sapropterin
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Javygtor
2611946BN -
Kuvan
751628BN
-
Javygtor
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sapropterin Oral Tablet
1102010SCDF -
Sapropterin dihydrochloride Oral Tablet
2649279SCDFP -
Sapropterin Oral Product
1157609SCDG -
Sapropterin Pill
1157610SCDG -
Sapropterin dihydrochloride Oral Product
2662130SCDGP -
Sapropterin dihydrochloride Pill
2660270SCDGP -
Sapropterin Oral Tablet [Javygtor]
2612670SBDF -
Sapropterin Oral Tablet [Kuvan]
1486689SBDF - +9 more in this family
-
Sapropterin Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sapropterin dihydrochloride 100 MG
1486686SCDC -
Sapropterin dihydrochloride 100 MG Oral Tablet [Javygtor]
2612671SBD -
Sapropterin dihydrochloride 100 MG Oral Tablet [Kuvan]
1486691SBD -
Sapropterin dihydrochloride 100 MG [Javygtor]
2611947SBDC -
Sapropterin dihydrochloride 100 MG [Kuvan]
1486688SBDC
-
Sapropterin dihydrochloride 100 MG
Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sapropterin dihydrochloride 100 MG
SCDC · 1486686 -
Sapropterin Oral Tablet
SCDF · 1102010 -
Sapropterin dihydrochloride Oral Tablet
SCDFP · 2649279 -
Sapropterin Oral Product
SCDG · 1157609 -
Sapropterin Pill
SCDG · 1157610 -
Sapropterin dihydrochloride Oral Product
SCDGP · 2662130 -
Sapropterin dihydrochloride Pill
SCDGP · 2660270
Brand-Name Concepts
-
Sapropterin dihydrochloride 100 MG Oral Tablet [Javygtor]
SBD · 2612671 -
Sapropterin dihydrochloride 100 MG Oral Tablet [Kuvan]
SBD · 1486691 -
Sapropterin dihydrochloride 100 MG [Javygtor]
SBDC · 2611947 -
Sapropterin dihydrochloride 100 MG [Kuvan]
SBDC · 1486688 -
Sapropterin Oral Tablet [Javygtor]
SBDF · 2612670 -
Sapropterin Oral Tablet [Kuvan]
SBDF · 1486689 -
Sapropterin dihydrochloride Oral Tablet [Javygtor]
SBDFP · 2657135 -
Sapropterin dihydrochloride Oral Tablet [Kuvan]
SBDFP · 2657249 -
Javygtor Oral Product
SBDG · 2611948 -
Javygtor Pill
SBDG · 2612669
📦 FDA Products & Package NDCs
9 products · 13 package NDCs
13 package NDCs map to RxCUI 1486687 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0906-23 | 120 TABLET in 1 BOTTLE (0054-0906-23) | sapropterin dihydrochloride | Hikma Pharmaceuticals USA Inc. | 2025-10-23 |
| 31722-0045-12 | 120 TABLET in 1 BOTTLE (31722-045-12) | sapropterin dihydrochloride | Camber Pharmaceuticals, Inc. | 2022-08-23 |
| 43598-0096-04 | 120 TABLET in 1 BOTTLE (43598-096-04) | JAVYGTOR | Dr. Reddys Laboratories Inc | 2022-10-03 |
| 43598-0096-05 | 500 TABLET in 1 BOTTLE (43598-096-05) | JAVYGTOR | Dr. Reddys Laboratories Inc | 2022-10-03 |
| 43598-0096-30 | 30 TABLET in 1 BOTTLE (43598-096-30) | JAVYGTOR | Dr. Reddys Laboratories Inc | 2022-10-03 |
| 49884-0720-08 | 120 TABLET in 1 BOTTLE (49884-720-08) | sapropterin dihydrochloride | Par Health USA, LLC | 2020-10-01 |
| 59651-0574-08 | 120 TABLET in 1 BOTTLE (59651-574-08) | Sapropterin Dihydrochloride | Aurobindo Pharma Limited | 2025-06-09 |
| 59651-0574-24 | 240 TABLET in 1 BOTTLE (59651-574-24) | Sapropterin Dihydrochloride | Aurobindo Pharma Limited | 2025-06-09 |
| 59651-0574-30 | 30 TABLET in 1 BOTTLE (59651-574-30) | Sapropterin Dihydrochloride | Aurobindo Pharma Limited | 2025-06-09 |
| 68135-0300-02 | 120 TABLET in 1 BOTTLE (68135-300-02) | Kuvan | BioMarin Pharmaceutical Inc. | 2007-12-14 |
| 68135-0301-22 | 30 PACKET in 1 CARTON (68135-301-22) / 1 POWDER, FOR SOLUTI... | Kuvan | BioMarin Pharmaceutical Inc. | 2014-02-21 |
| 68135-0482-11 | 30 PACKET in 1 CARTON (68135-482-11) / 1 POWDER, FOR SOLUTI... | Kuvan | BioMarin Pharmaceutical Inc. | 2015-05-27 |
| 72603-0191-01 | 120 TABLET in 1 BOTTLE (72603-191-01) | sapropterin dihydrochloride | NorthStar RxLLC | 2023-12-01 |
Observed labelers:
Aurobindo Pharma Limited (3) ·
BioMarin Pharmaceutical Inc. (3) ·
Dr. Reddys Laboratories Inc (3) ·
Camber Pharmaceuticals, Inc. (1) ·
Hikma Pharmaceuticals USA Inc. (1) ·
NorthStar RxLLC (1)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.